Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldblatt

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
The Pediatric Infectious Disease Journal|January 3, 2020
A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in AdultsCheryl A Keech, Royce Morrison, Porter Anderson, et al.
Vaccine|July 2, 2021
Evidence for antibody as a protective correlate for COVID-19 vaccinesKristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, et al.
The Pediatric Infectious Disease Journal|February 16, 2012
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdomHelen Findlow, Ray Borrow, Nick Andrews, et al.
European Journal of Immunology|June 6, 2009
Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniaeClaire M Smith, Carla Lo Passo, Angela Scuderi, et al.
Journal of Clinical Immunology|March 15, 2019
Health-Related Quality of Life and Emotional Health in X-Linked Carriers of Chronic Granulomatous Disease in the United KingdomAlexandra C Battersby, Helen Braggins, Mark S Pearce, et al.
The Lancet. Infectious Diseases|July 22, 2014
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort studyNick J Andrews, Pauline A Waight, Polly Burbidge, et al.
Vaccines|June 24, 2022
Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination SeraHenning Jacobsen, Ioannis Sitaras, Marley Jurgensmeyer, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2006
Effect of month of vaccine administration on antibody responses in The Gambia and PakistanSophie E Moore, Andrew C Collinson, Anthony J C Fulford, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 10, 2020
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2Marina Johnson, Helen R Wagstaffe, Kimberly C Gilmour, et al.
AIDS (London, England)|September 2, 2005
Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infantLisa M McNally, Prakash M Jeena, Umesh Lalloo, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
The Pediatric Infectious Disease Journal|January 3, 2020
A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in AdultsCheryl A Keech, Royce Morrison, Porter Anderson, et al.
Vaccine|July 2, 2021
Evidence for antibody as a protective correlate for COVID-19 vaccinesKristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, et al.
The Pediatric Infectious Disease Journal|February 16, 2012
Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdomHelen Findlow, Ray Borrow, Nick Andrews, et al.
European Journal of Immunology|June 6, 2009
Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniaeClaire M Smith, Carla Lo Passo, Angela Scuderi, et al.
Journal of Clinical Immunology|March 15, 2019
Health-Related Quality of Life and Emotional Health in X-Linked Carriers of Chronic Granulomatous Disease in the United KingdomAlexandra C Battersby, Helen Braggins, Mark S Pearce, et al.
The Lancet. Infectious Diseases|July 22, 2014
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort studyNick J Andrews, Pauline A Waight, Polly Burbidge, et al.
Vaccines|June 24, 2022
Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination SeraHenning Jacobsen, Ioannis Sitaras, Marley Jurgensmeyer, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2006
Effect of month of vaccine administration on antibody responses in The Gambia and PakistanSophie E Moore, Andrew C Collinson, Anthony J C Fulford, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 10, 2020
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2Marina Johnson, Helen R Wagstaffe, Kimberly C Gilmour, et al.
AIDS (London, England)|September 2, 2005
Probable mother to infant transmission of Pneumocystis jiroveci from an HIV-infected woman to her HIV-uninfected infantLisa M McNally, Prakash M Jeena, Umesh Lalloo, et al.
Pageof 25